Biochemical and Biophysical Research Communications 1991-12-31

Adenosine (A2) antagonist inhibits induction of long-term potentiation of evoked synaptic potentials but not of the population spike in hippocampal CA1 neurons.

Y Sekino, K Ito, H Miyakawa, H Kato, Y Kuroda

Index: Biochem. Biophys. Res. Commun. 181(3) , 1010-4, (1991)

Full Text: HTML

Abstract

The effects of adenosine A2 receptor antagonist (CP-66713) on long-term potentiation were studied using guinea pig hippocampal slices in a perfusion system. Tetanic stimulation of Schaffer collateral input which was applied during perfusion of CP-66713 (10 microM), did not induce long-term potentiation but rather long-term depression of evoked synaptic potentials (field EPSP), but induced long-term potentiation of the population spike in CA1 neurons. Thus, adenosine derivatives which accumulate in the synaptic cleft during the tetanic stimulation may be involved in induction of the long-term potentiation via A2 receptors at the synapse. The clear discrimination between long-term depression of the field EPSP and long-term potentiation of the population spike suggests EPSP-spike potentiation at the postsynaptic sites.

Related Compounds

  • 8-chloro-1-phenyl-...

Related Articles:

Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.

1999-09-10

[Eur. J. Pharmacol. 380(2-3) , 197-202, (1999)]

Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors.

1996-10-17

[Eur. J. Pharmacol. 313(3) , 237-42, (1996)]

Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

1993-11-01

[Br. J. Pharmacol. 110(3) , 949-54, (1993)]

Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.

1993-01-01

[Psychopharmacology 111(3) , 383-8, (1993)]

Adenosine-induced relaxation of cultured bovine retinal pericytes.

1997-12-01

[Invest. Ophthalmol. Vis. Sci. 38(13) , 2695-701, (1997)]

More Articles...